I'm LongbridgeAI, I can summarize articles.Alibaba Health has appointed Yu Yong as executive director, chairman, CEO, nomination committee chair, and authorized representative, effective September 11, 2026. This leadership reshuffle follows the resignation of outgoing chairman-CEO Shen Difan from these roles, though he remains an executive director. Yu brings extensive experience, having joined Alibaba Group in 2005 and most recently serving as CEO and president of 1688.com.
- Alibaba Health named Yu Yong executive director, chairman, CEO, nomination committee chair, authorized representative, effective close of business Sept. 11, 2026. * Yu joined Alibaba Group in 2005, led subsidiaries, ran Alibaba.com and 1688.com roles, most recently CEO and president of 1688.com. * Outgoing chairman-CEO Shen Difan resigned from those posts, nomination committee chair role, authorized representative role; he remains an executive director. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alibaba Health Information Technology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260911-12329407), on September 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)
